Oregon Proposes Drug Price Transparency Program Updates

Oregon — The Oregon Division of Financial Regulation recently announced the following proposed rulemaking: Filing Caption: Prescription Drug Price Transparency program updates

Rules Proposed: 836-200-0505, 836-200-0515, 836-200-0520, 836-200-0530, 836-200-0531, 836-200-0532, 836-200-0533, 836-200-0535, 836-200-0545, 836-200-0555

Rules Summary: These proposed changes add a clarifying definition for “drug;” correct internal references; revert annual price increase reporting from voluntary to mandatory per a recent court judgment; clarify language about the timing of data reporting; add examples of factors that may contribute to price increases; update the threshold for reporting new prescription drugs; and add minor data collection points to allow for DPT program staff verification.

Filed: July 29, 2026

Hearing date/time: August 26, 2026, 9:30 AM

Last Day and Time to Offer Comment to Agency: September 2, 2026, 5:00 PM